Chronix granted Myriad Genetics exclusive rights to technology for the early detection of breast, colon and prostate cancers in North and South America and Europe

Chronix Biomedical

U.S. / Medical Devices and Diagnostics

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Myriad Genetics Inc.

U.S. / Medical Devices and Diagnostics

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced